Induction Dosage of Propofol for Repeated Sedations in Children With Hematological Disorders

Alessandra Moretto, Alberto Zanella, Valentina Ciceri, Matteo Rota, Vittorio Scaravilli, Virginia Beltrama, Mariagrazia Bosatra, Antonio Pesenti

Research output: Contribution to journalArticle

Abstract

Pediatric patients with hematologic malignancies require several procedural sedations by means of propofol infusion. We retrospectively analyzed the medical records of leukemic pediatric patients who had undergone procedural sedations at an Italian tertiary referral center (San Gerardo Hospital, Monza) from January 2011 to November 2013. We retrieved the following: demographics; diagnosis; chemotherapy phase; use of corticosteroids; induction dosage of propofol, fentanyl and/or ketamine; and the type of procedure. We used a multivariate linear mixed model to evaluate the factors affecting induction propofol dose. We analyzed 1459 procedures (59% lumbar punctures, 31% bone marrow aspirations) performed on 96 children (7 [4-10] y old, 24 [16-34] kg, 37% female) admitted for acute lymphoblastic leukemia (80%), lymphoma (11%), and acute myeloid leukemia (7%). The induction propofol dose increased by 0.03 mg/kg per each procedure (P<0.05), from 2.6 (2.0-3.2) to 3.5 (2.6-4.3) mg/kg at the first and the last procedure, respectively. Higher age, weight, and use of ketamine were associated to lower propofol dosage (P<0.01), while combined procedures increased propofol dosage (P<0.01). In a large cohort of leukemic pediatric patients undergoing procedural sedation, the induction dose of propofol was increased over time, regardless of weight, age, use of corticosteroids, diagnosis, and treatment phase.

Original languageEnglish
Pages (from-to)e295-e298
JournalJournal of Pediatric Hematology/Oncology
Volume40
Issue number5
DOIs
Publication statusPublished - 2018

Fingerprint

Propofol
Ketamine
Pediatrics
Adrenal Cortex Hormones
Weights and Measures
Spinal Puncture
Fentanyl
Hematologic Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tertiary Care Centers
Acute Myeloid Leukemia
Medical Records
Linear Models
Lymphoma
Bone Marrow
Demography
Drug Therapy

Keywords

  • anesthesia
  • child
  • leukemia
  • propofol
  • retrospective study

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Induction Dosage of Propofol for Repeated Sedations in Children With Hematological Disorders. / Moretto, Alessandra; Zanella, Alberto; Ciceri, Valentina; Rota, Matteo; Scaravilli, Vittorio; Beltrama, Virginia; Bosatra, Mariagrazia; Pesenti, Antonio.

In: Journal of Pediatric Hematology/Oncology, Vol. 40, No. 5, 2018, p. e295-e298.

Research output: Contribution to journalArticle

Moretto, Alessandra ; Zanella, Alberto ; Ciceri, Valentina ; Rota, Matteo ; Scaravilli, Vittorio ; Beltrama, Virginia ; Bosatra, Mariagrazia ; Pesenti, Antonio. / Induction Dosage of Propofol for Repeated Sedations in Children With Hematological Disorders. In: Journal of Pediatric Hematology/Oncology. 2018 ; Vol. 40, No. 5. pp. e295-e298.
@article{aacc10f4b9ec4abd9371bc9fb2603227,
title = "Induction Dosage of Propofol for Repeated Sedations in Children With Hematological Disorders",
abstract = "Pediatric patients with hematologic malignancies require several procedural sedations by means of propofol infusion. We retrospectively analyzed the medical records of leukemic pediatric patients who had undergone procedural sedations at an Italian tertiary referral center (San Gerardo Hospital, Monza) from January 2011 to November 2013. We retrieved the following: demographics; diagnosis; chemotherapy phase; use of corticosteroids; induction dosage of propofol, fentanyl and/or ketamine; and the type of procedure. We used a multivariate linear mixed model to evaluate the factors affecting induction propofol dose. We analyzed 1459 procedures (59{\%} lumbar punctures, 31{\%} bone marrow aspirations) performed on 96 children (7 [4-10] y old, 24 [16-34] kg, 37{\%} female) admitted for acute lymphoblastic leukemia (80{\%}), lymphoma (11{\%}), and acute myeloid leukemia (7{\%}). The induction propofol dose increased by 0.03 mg/kg per each procedure (P<0.05), from 2.6 (2.0-3.2) to 3.5 (2.6-4.3) mg/kg at the first and the last procedure, respectively. Higher age, weight, and use of ketamine were associated to lower propofol dosage (P<0.01), while combined procedures increased propofol dosage (P<0.01). In a large cohort of leukemic pediatric patients undergoing procedural sedation, the induction dose of propofol was increased over time, regardless of weight, age, use of corticosteroids, diagnosis, and treatment phase.",
keywords = "anesthesia, child, leukemia, propofol, retrospective study",
author = "Alessandra Moretto and Alberto Zanella and Valentina Ciceri and Matteo Rota and Vittorio Scaravilli and Virginia Beltrama and Mariagrazia Bosatra and Antonio Pesenti",
year = "2018",
doi = "10.1097/MPH.0000000000001145",
language = "English",
volume = "40",
pages = "e295--e298",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Induction Dosage of Propofol for Repeated Sedations in Children With Hematological Disorders

AU - Moretto, Alessandra

AU - Zanella, Alberto

AU - Ciceri, Valentina

AU - Rota, Matteo

AU - Scaravilli, Vittorio

AU - Beltrama, Virginia

AU - Bosatra, Mariagrazia

AU - Pesenti, Antonio

PY - 2018

Y1 - 2018

N2 - Pediatric patients with hematologic malignancies require several procedural sedations by means of propofol infusion. We retrospectively analyzed the medical records of leukemic pediatric patients who had undergone procedural sedations at an Italian tertiary referral center (San Gerardo Hospital, Monza) from January 2011 to November 2013. We retrieved the following: demographics; diagnosis; chemotherapy phase; use of corticosteroids; induction dosage of propofol, fentanyl and/or ketamine; and the type of procedure. We used a multivariate linear mixed model to evaluate the factors affecting induction propofol dose. We analyzed 1459 procedures (59% lumbar punctures, 31% bone marrow aspirations) performed on 96 children (7 [4-10] y old, 24 [16-34] kg, 37% female) admitted for acute lymphoblastic leukemia (80%), lymphoma (11%), and acute myeloid leukemia (7%). The induction propofol dose increased by 0.03 mg/kg per each procedure (P<0.05), from 2.6 (2.0-3.2) to 3.5 (2.6-4.3) mg/kg at the first and the last procedure, respectively. Higher age, weight, and use of ketamine were associated to lower propofol dosage (P<0.01), while combined procedures increased propofol dosage (P<0.01). In a large cohort of leukemic pediatric patients undergoing procedural sedation, the induction dose of propofol was increased over time, regardless of weight, age, use of corticosteroids, diagnosis, and treatment phase.

AB - Pediatric patients with hematologic malignancies require several procedural sedations by means of propofol infusion. We retrospectively analyzed the medical records of leukemic pediatric patients who had undergone procedural sedations at an Italian tertiary referral center (San Gerardo Hospital, Monza) from January 2011 to November 2013. We retrieved the following: demographics; diagnosis; chemotherapy phase; use of corticosteroids; induction dosage of propofol, fentanyl and/or ketamine; and the type of procedure. We used a multivariate linear mixed model to evaluate the factors affecting induction propofol dose. We analyzed 1459 procedures (59% lumbar punctures, 31% bone marrow aspirations) performed on 96 children (7 [4-10] y old, 24 [16-34] kg, 37% female) admitted for acute lymphoblastic leukemia (80%), lymphoma (11%), and acute myeloid leukemia (7%). The induction propofol dose increased by 0.03 mg/kg per each procedure (P<0.05), from 2.6 (2.0-3.2) to 3.5 (2.6-4.3) mg/kg at the first and the last procedure, respectively. Higher age, weight, and use of ketamine were associated to lower propofol dosage (P<0.01), while combined procedures increased propofol dosage (P<0.01). In a large cohort of leukemic pediatric patients undergoing procedural sedation, the induction dose of propofol was increased over time, regardless of weight, age, use of corticosteroids, diagnosis, and treatment phase.

KW - anesthesia

KW - child

KW - leukemia

KW - propofol

KW - retrospective study

UR - http://www.scopus.com/inward/record.url?scp=85046019247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046019247&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000001145

DO - 10.1097/MPH.0000000000001145

M3 - Article

AN - SCOPUS:85046019247

VL - 40

SP - e295-e298

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 5

ER -